Search

Daren Ure Phones & Addresses

  • 2315 22Nd St, Rochester, MN 55901 (507) 282-0952

Publications

Us Patents

Dendritic Cell Potentiation

View page
US Patent:
7052694, May 30, 2006
Filed:
Jul 16, 2002
Appl. No.:
10/196601
Inventors:
Larry R. Pease - Rochester MN, US
Moses Rodriguez - Rochester MN, US
Daren Ure - Rochester MN, US
Loc T. Nguyen - Rochester MN, US
Suresh Radhakrishnan - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A61K 39/395
C07K 16/28
US Classification:
4241721, 53038815, 5303882, 53038822, 5303887, 53038873, 5303891, 5303896, 4241431, 4241441, 4241421, 4241521, 4241531, 4241731, 4242781, 424 931, 424 937
Abstract:
A molecule capable of potentiating immune responses is described, as well as methods for using the molecule to enhance immune responses and enhance dendritic cell function. Also described are compositions containing the molecule and methods for using the compositions to treat or immunize individuals.

Dendritic Cell Potentiation

View page
US Patent:
7390888, Jun 24, 2008
Filed:
Jul 8, 2005
Appl. No.:
11/178160
Inventors:
Larry R. Pease - Rochester MN, US
Moses Rodriguez - Rochester MN, US
Daren Ure - Rochester MN, US
Loc T. Nguyen - Rochester MN, US
Suresh Radhakrishnan - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A61K 39/395
A61K 35/00
C07K 16/18
US Classification:
53038815, 4241721, 424808
Abstract:
A molecule capable of potentiating immune responses is described, as well as methods for using the molecule to enhance immune responses and enhance dendritic cell function. Also described are compositions containing the molecule and methods for using the compositions to treat or immunize individuals.

Treatment Of Central Nervous System Diseases By Antibodies Against Glatiramer Acetate

View page
US Patent:
20020182210, Dec 5, 2002
Filed:
Jun 20, 2001
Appl. No.:
09/885227
Inventors:
Moses Rodriguez - Rochester MN, US
Daren Ure - Rochester MN, US
International Classification:
A61K039/395
C07K016/40
US Classification:
424/141100, 530/388150
Abstract:
The present invention provides humanized polyclonal and humanized monoclonal antibodies directed against an epitope on glatiramer acetate, also known as Copolymer 1, Copolymer-1, Cop-1 or Cop. Additionally, the subject invention concerns a pharmaceutical composition comprising an antibody directed against an epitope on glatiramer acetate for the treatment of a disease associated with demyelination of central nervous system axons. Also encompassed by the subject invention is a method of treating a subject suffering from a disease associated with demyelination of central nervous system axons. The subject invention further contains methods of stimulating remyelination of central nervous system axons. In addition, the subject invention provides a method of stimulating proliferation of lymphocytes.

Treatment Of Central Nervous System Diseases By Antibodies Against Glatiramer Acetate

View page
US Patent:
20050019322, Jan 27, 2005
Filed:
Feb 10, 2004
Appl. No.:
10/776442
Inventors:
Moses Rodriguez - Rochester MN, US
Daren Ure - Rochester MN, US
International Classification:
A61K039/395
US Classification:
424131100, 530387200
Abstract:
The present invention provides humanized polyclonal and humanized monoclonal antibodies directed against an epitope on glatiramer acetate, also known as Copolymer 1, Copolymer-1, Cop-or Cop. Additionally, the subject invention concerns a pharmaceutical composition comprising an antibody directed against an epitope on glatiramer acetate for the treatment of a disease associated with demyelination of central nervous system axons. Also encompassed by the subject invention is a method of treating a subject suffering from a disease associated with demyelination of central nervous system axons. The subject invention further contains methods of stimulating remyelination of central nervous system axons. In addition, the subject invention provides a method of stimulating proliferation of lymphocytes.

Dendritic Cell Potentiation

View page
US Patent:
20080193467, Aug 14, 2008
Filed:
Apr 15, 2008
Appl. No.:
12/103362
Inventors:
Larry R. Pease - Rochester MN, US
Moses Rodriguez - Rochester MN, US
Daren Ure - Rochester MN, US
Loc T. Nguyen - Rochester MN, US
Suresh Radhakrishnan - Rochester MN, US
International Classification:
A61K 39/395
A61K 39/00
A61K 35/12
A61P 37/00
US Classification:
4241721, 4242781, 4242771, 4242041, 4242341, 424 937
Abstract:
A molecule capable of potentiating immune responses is described, as well as methods for using the molecule to enhance immune responses and enhance dendritic cell function. Also described are compositions containing the molecule and methods for using the compositions to treat or immunize individuals.

Dendritic Cell Potentiation

View page
US Patent:
20100009438, Jan 14, 2010
Filed:
Aug 14, 2009
Appl. No.:
12/541698
Inventors:
Larry R. Pease - Rochester MN, US
Moses Rodriguez - Rochester MN, US
Daren Ure - Rochester MN, US
Loc T. Nguyen - Rochester MN, US
Suresh Radhakrishnan - Rochester MN, US
International Classification:
C12N 5/06
C12N 15/11
C12N 15/00
US Classification:
435325, 536 235, 536 2353, 4353201
Abstract:
A molecule capable of potentiating immune responses is described, as well as methods for using the molecule to enhance immune responses and enhance dendritic cell function. Also described are compositions containing the molecule and methods for using the compositions to treat or immunize individuals.

Dendritic Cell Potentiation

View page
US Patent:
20100015163, Jan 21, 2010
Filed:
Aug 27, 2009
Appl. No.:
12/548925
Inventors:
Larry R. Pease - Rochester MN, US
Moses Rodriguez - Rochester MN, US
Daren Ure - Rochester MN, US
Loc T. Nguyen - Rochester MN, US
Suresh Radhakrishnan - Rochester MN, US
International Classification:
A61K 39/395
A61P 37/00
US Classification:
4241721
Abstract:
A molecule capable of potentiating immune responses is described, as well as methods for using the molecule to enhance immune responses and enhance dendritic cell function. Also described are compositions containing the molecule and methods for using the compositions to treat or immunize individuals.
Daren R Ure from Rochester, MN, age ~57 Get Report